Evidence map›Paper›PMID 30348763›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Structural and mechanistic insights into the function of the unconventional class XIV myosin MyoA from

Cameron J Powell, Raghavendran Ramaswamy, Anne Kelsen, David J Hamelin, David M Warshaw, Jürgen Bosch, John E Burke, Gary E Ward, Martin J Boulanger

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Organization of Myosin H in the Apical Complex ofbioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Full-lengtheLife · 2020
    Article
  13. Review
  14. Peptide Probes forACS chemical biology · 2020
    Article
  15. iTRAQ-Based Phosphoproteomic Analysis ofFrontiers in cellular and infection microbiology · 2020
    Article
  16. Article
  17. Dynamic structural biology at the protein membrane interface.The Journal of biological chemistry · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Cameron J PowellDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada.
Raghavendran RamaswamyDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada.
Anne KelsenDepartment of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT 05405.
David J HamelinDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada.
David M WarshawDepartment of Molecular Physiology and Biophysics, University of Vermont Larner College of Medicine, Burlington, VT 05405.
Jürgen BoschDivision of Pulmonology and Allergy/Immunology, Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
John E BurkeDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada.ORCID 0000-0001-7904-9859
Gary E WardDepartment of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT 05405.
Martin J BoulangerDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada; mboulang@uvic.ca.
University of Victoria · CAUniversity of Vermont · USCase Western Reserve University · US

Funding

VERMONT IMMUNOBIOLOIGY/ INFECTIOUS DISEASES CENTERP20RR021905 · NCRR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2006 to 2011
$14.5M
Project 3 - Personalized cystic fibrosis treatment strategies with synergistic therapies Identified in vitro.P01HL128192 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI GASTON, BENJAMIN · 2016 to 2020
$12.2M
Vermont Immunology/Infectious Diseases CenterP30GM118228 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2016 to 2021
$6.8M
Small Molecule Approaches to Studying T. gondii InvasionR01AI054961 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI WARD, GARY E · 2003 to 2014
$4.5M
Multiscale analysis of MyosinA-based motility in Toxoplasma gondiiR01AI139201 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI WARD, GARY E · 2019 to 2023
$2.8M
Myosin Va Cargo Transport: In Vitro Model SystemsR01GM094229 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI WARSHAW, DAVID M · 2011 to 2020
$2.7M
Small Molecule Approaches to Studying T. gondi InvasionR56AI054961 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI WARD, GARY E · 2008 to 2008
$312k
CIHR 148596NCRR NIH HHS P20 RR021905NHLBI NIH HHS P01 HL128192NIAID NIH HHS R01 AI054961NIAID NIH HHS R01 AI139201NIAID NIH HHS R56 AI054961NIGMS NIH HHS P30 GM118228NIGMS NIH HHS R01 GM094229
6 · The paper itself

Abstract

Parasites of the phylum Apicomplexa are responsible for significant morbidity and mortality on a global scale. Central to the virulence of these pathogens are the phylum-specific, unconventional class XIV myosins that power the essential processes of parasite motility and host cell invasion. Notably, class XIV myosins differ from human myosins in key functional regions, yet they are capable of fast movement along actin filaments with kinetics rivaling previously studied myosins. Toward establishing a detailed molecular mechanism of class XIV motility, we determined the 2.6-Å resolution crystal structure of the

Indexed as

Amino Acid SequenceAntiprotozoal AgentsBinding SitesDrug DesignMolecular MimicryMutationNonmuscle Myosin Type IIAProtein BindingProtein ConformationProtein StabilitySequence Homology, Amino AcidToxoplasmaAntiprotozoal AgentsNonmuscle Myosin Type IIAApicomplexamotilitymyosinToxoplasma gondiiX-ray crystallography

Identifiers

PMID30348763
PMCPMC6233092
OpenAlexW2896727919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.